In private equity, “operational improvement” can be a phrase with the nutritional value of packing foam. Regal Healthcare Capital Partners gets more specific. It talks about appointment starts. Door-to-provider time. Call-center performance. Where the next clinic should open. How many people should be scheduled for a volume that has not arrived yet. The New York firm’s investment thesis lives in the small indignities and hidden frictions of receiving care - the voicemail, the wait, the form, the empty Saturday appointment slot.
That specificity reflects the pairing at Regal’s center. David Kim is an emergency physician and serial healthcare entrepreneur who helped build CityMD/Premier Care Urgent Care, Dental365 and Progressive Emergency Physicians. Jon Santemma spent decades advising healthcare companies and led global healthcare investment banking at Jefferies before co-founding Regal with Kim in 2018. One knows what a clinical operation feels like from inside; the other knows how companies are financed, combined and sold.
They chose a narrow patch of ground: control growth equity and buyouts at the smaller end of the lower middle market, exclusively in healthcare services. Regal’s published target tends to be a regional leader with $20 million to $100 million in revenue, $2 million to $10 million in EBITDA, an experienced management team and enough clinical credibility to be worth preserving. These are not drug-discovery moonshots or medical-device laboratories. They are care businesses with schedules, clinicians, leases, phone queues and local reputations.
A roll-up with a bedside manner
Healthcare services are often fragmented by design and history. A respected physician group may dominate one city but lack the systems, capital or appetite to become a regional network. Billing practices differ. Technology stacks do not talk. Recruiting is local. A founder may be both chief clinician and unofficial head of operations. The opportunity for a sponsor is familiar: buy or build a platform, add practices, centralize suitable functions and spread a repeatable model.
Regal’s variation is what it calls “physician-backed capital.” The phrase does not mean that every decision is clinical, or that finance disappears. It means the firm presents medical and operating experience as part of the capital package. Its portfolio-facing work includes KPI dashboards, data-led site selection, predictive volume forecasting, staffing models and efforts to remove waste. On the clinical side, it promotes physician leadership, review committees, training and incentive plans intended to reward providers as the business grows.
“I truly believe that walking the walk matters more than talking the talk.”
David Kim, co-founder and general partner
The customer, in the immediate business sense, is a healthcare founder or executive looking for equity and an operating partner. Behind that person sit two other constituencies. Patients have to experience better access and reliable care. Limited partners - endowments, foundations, asset managers, consultants and pension plans among them - expect investment returns. Regal’s model has to make those interests coexist, at least long enough to create an enterprise that another owner will value.
Twelve doors into one thesis
The public portfolio reads less like a conventional sector list than the directory of a very ambitious medical building. Regal describes businesses across autism services, dentistry, dermatology, emergency-room management, fertility, healthcare staffing, in-home healthcare, outpatient mental health, non-medical home care, psychiatric crisis services, eyecare and kidney disease management. The clinical needs differ sharply. The operating pattern is more consistent: local or regional delivery, recurring demand, skilled providers and room to extend a platform across locations.
Dental365 is the cleanest public window into the playbook. Kim co-founded the business with dentist Scott Asnis in 2014. By the time The Jordan Company agreed to acquire it in 2021, Dental365 had nearly 70 locations across the New York metropolitan area, Connecticut and New Jersey, more than 165 dentists, 800 staff members and over 400,000 annual patient visits. Regal and the founders remained minority investors. It is an example of the platform arc in miniature: create, professionalize, expand, bring in a larger pool of capital and keep some exposure to what comes next.
Thriveworks shows another route. Regal invested in the mental-health provider’s management services organization in 2019. When a later financing led by Wellington Management arrived in 2021, alongside Fidelity, RA Capital, Redmile and Transformation Capital, Regal remained the largest equity holder. At that point Thriveworks said it had more than 310 centers, over 2,000 clinicians and a substantial virtual counseling business. Regal did not need a full exit to introduce new capital to a scaling company.
InFocus Eyecare, formed in 2022 with veteran optical executive Ryan Williams, began closer to the blank-sheet end of the spectrum. Regal committed to fund the platform from its third fund, while Williams brought experience growing a Pearle Vision franchisee from 10 to more than 80 locations. The stated plan was to preserve the legacy of affiliated practices while adding operating support and expanding patient services - a compact summary of the promise every healthcare roll-up makes and then has to deliver.
The funds got big. The target stayed small.
Regal’s capital base has climbed quickly. Its second fund closed at a $165 million hard cap in 2019, above a $125 million target. Fund III closed in 2021 at $415 million, also at its hard cap, after less than a month of fundraising. Roughly $350 million came from investors in earlier Regal funds, while the general partners committed more than $100 million alongside it. In July 2026, Fund IV closed at $610 million, including about $575 million of external commitments, against an original $550 million target.
Across four funds, the firm now reports nearly $1.3 billion in aggregate commitments. The math matters because the niche has not visibly moved upmarket with the fund size. Regal still advertises that $20 million to $100 million revenue box. A larger pool can support more platforms, follow-on acquisitions and longer growth plans, but it also creates pressure to put money to work. The discipline lies in keeping a narrow strategy from becoming a narrow label pasted over broader deals.
The test beneath the thesis
Private equity ownership of healthcare providers attracts scrutiny over cost, leverage, staffing and clinical autonomy. Regal’s answer is alignment: clinical leadership in the executive suite, provider-focused training, patient satisfaction measures and businesses with relatively low reimbursement exposure. Those are useful design choices, not proof by themselves. The durable evidence will be whether access and quality improve through ownership changes, not simply whether a platform adds locations.
Where Regal sits
The market around Regal is crowded. Healthcare specialists such as Hildred Capital, Varsity Healthcare Partners, Enhanced Healthcare Partners and Webster Equity Partners pursue overlapping parts of the middle market, while generalist firms routinely build provider-services platforms. Regal is smaller and more tightly bounded than many national buyout franchises. Its distinction is a founder story that doubles as an operating model: physician-entrepreneur plus healthcare financier, supported by investment staff, payor and revenue-cycle specialists, technology advisers and a network of former executives.
That puts Regal between a conventional financial sponsor and an operating partner built for one industry. It sells neither software nor medical care itself. Its product is the combination of patient capital, healthcare pattern recognition and a repeatable method for making regional providers easier to run.
Its ideal founder is not shopping only for the highest bid. That person wants help turning a regional care business into a system - without making clinicians feel as if a spreadsheet has been appointed chief medical officer. Regal’s culture, at least as presented publicly, is collaborative and bluntly measurable. Providers are treated as the engines of the business. Patient experience is not confined to bedside behavior; it includes whether someone can get a same-day appointment, whether the visit begins on time and whether a text reminder prevents a missed slot.
This is the most stealable part of Regal’s playbook. Start with the customer’s clock. Measure the friction that an executive summary edits out. Pair capital with people who have lived through the operational problem. Then make the growth model travel from one clinic to the next. None of that makes healthcare consolidation automatically good. It does make the proposition testable. If the phone gets answered, the clinician has support, the patient gets seen sooner and the numbers still work, the slogan has earned its place.
Keep reading and listening
Regal publishes its investment criteria, team, portfolio categories and firm announcements on its website. Its LinkedIn page carries hiring and portfolio updates. For a more conversational view, partner Terry Wang’s behavioral-health interview explains how the firm segments care from routine counseling through psychiatric crisis services.